---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-132583"
form_type: "8-K"
ticker: "CRVS"
cik: "0001626971"
company_name: "Corvus Pharmaceuticals, Inc."
filed_at: "2021-11-02T23:59:59+00:00"
generated_at: "2026-06-28T15:11:29.083969+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Corvus enters $40M ATM equity offering with Jefferies LLC

## Summary
- Sales agreement for up to $40M in common stock, Jefferies as sales agent.
- Jefferies receives up to 3% commission on gross proceeds from sales.
- Sales may occur through Nasdaq, block trades, or privately negotiated transactions.
- Company may suspend or terminate the agreement at any time; no obligation to sell shares.

## SEC filing metadata
- accession: 0001104659-21-132583
- form_type: 8-K
- ticker: CRVS
- cik: 0001626971
- company_name: Corvus Pharmaceuticals, Inc.
- filed_at: 2021-11-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626971/000110465921132583/0001104659-21-132583-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626971/000110465921132583/tm2131487d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-132583
- JSON: https://secwatch.observer/filing/0001104659-21-132583.json
- Plain text: https://secwatch.observer/filing/0001104659-21-132583.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.